Log in to save to my catalogue

Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expressi...

Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expressi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2577745270

Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components

About this item

Full title

Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components

Publisher

Dordrecht: Springer Netherlands

Journal title

Molecular biology reports, 2021-01, Vol.48 (1), p.551-562

Language

English

Formats

Publication information

Publisher

Dordrecht: Springer Netherlands

More information

Scope and Contents

Contents

Recently, our group showed that Romidepsin, a histone deacetylase inhibitor (HDACi), suppressed diethylnitrosamine (DEN)-induced hepatocellular carcinoma (HCC) in mice. In the present study, we investigated the effect of Romidepsin-treatment on gene expression levels of components of Bmp and Notch signaling pathways, which are both known to be aber...

Alternative Titles

Full title

Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2577745270

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2577745270

Other Identifiers

ISSN

0301-4851

E-ISSN

1573-4978

DOI

10.1007/s11033-020-06089-9

How to access this item